| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |